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Abstract: Chemical investigation of the Mediterranean sponge Sarcotragus spinosulus led 
to the isolation of a new hydroxylated nonaprenylhydroquinone, along with two known 
metabolites, hepta- and octaprenylhydroquinones. The structure of the new metabolite was 
assigned by extensive 1D and 2D NMR analyses and MS studies. The antileukemic effect 
of the three compounds towards the chronic myelogenous leukemia (CML) cells line K562 
was also evaluated. 
Keywords:  sponges;  Sarcotragus  spinosulus;  marine  natural  products;  hydroxylated 
polyprenylhydroquinone; bioactivity 
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1. Introduction  
Several linear and cyclic prenylated hydroquinones and related secondary metabolites have been 
isolated  from  sponges  [1–6],  tunicates  [7,8],  and  algae  [9,10].  A  large  number  of  linear 
polyprenylhydroquinones  have  been  isolated  from  sponges,  especially  from  the  Irciniidae  
family  (mainly  from  the  genera  Ircinia  and  Sarcotragus).  Biological  studies  conducted  on  
several  polyprenylhydroquinones  showed  them  to  have  a  moderate  antibacterial  [11,12],  
antiviral  [13],  anti-inflammatory  [14,15],  and  phospholipase  A2  activity  [15].  These  linear 
polyprenylhydroquinones could be further divided in two main groups with polyprenylhydroquinones 
sulfates  [16–20]  and  hydroxylated  polyprenylhydroquinones.  To  date  only  four  hydroxylated 
polyprenylhydroquinones [5,6,20,21] have been isolated from Sarcotragus spinosulus (under the name 
Ircinia  spinosula).  They  have  been  shown  to  have  an  enhanced  antibacterial,  anti-inflammatory, 
cytotoxic [12,15], and antioxidant activity [22] potentially associated to the presence of the hydroxyl 
group on the prenyl side chain. 
In  the  course  of  our  search  for  bioactive  marine  natural  products,  we  have  investigated  the 
Mediterranean  marine  sponge  Sarcotragus  spinosulus  (Dictyoceratida,  Irciniidae)  collected  from 
Callejones,  Ceuta.  In  this  paper  we  report  the  isolation  and  structural  elucidation  of  a  new 
hydroxylated nonaprenylhydroquinone, along with two known polyprenylhydroquinones, hepta- and 
octaprenylhydroquinones. We also report the antileukemic effect of the three compounds towards the 
chronic myelogenous leukemia (CML) cells line K562. 
2. Results and Discussion 
The CH2Cl2/MeOH (1:1, v/v) crude extract of Sarcotragus spinosulus was fractionated by Flash 
Vacuum Liquid Chromatography, eluting with a gradient of decreasing polarity from H2O to MeOH. 
The subsequent MeOH fraction was purified by semipreparative reverse-phase HPLC (Phenomenex 
Luna C6-Pheny, 250 ×  10 mm id, 5 µm, gradient H2O/MeCN/Formic Acid, 96:04:0.1 to 0:100:0.1) to 
afford pure compounds 1 (41.7 mg), 2 (30.6 mg), and 3 (4.7 mg) (Figure 1). 
Figure 1. Structure of compounds 1, 2, and 3. 
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A preliminary NMR spectral analysis of all isolated compounds showed similarities and strongly 
supported the presence of a 2-polyprenylhydroquinone skeleton in each. Compounds 1–3 showed the 
same UV (280 nm) and IR (3350, 1500, 1445, 910, 785, 730 cm
−1) spectra, indicating the presence of a 
monosubstituted  hydroquinone  structure.  This  was  supported  by  the  occurrence  of  three  aromatic Mar. Drugs 2011, 9  
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protons in the 
1H NMR spectrum, two doublets at δ 6.56 (J = 8.5 Hz) and 6.52 (J = 3.0 Hz), and a 
double doublet at δ 6.57 (J = 8.5 and 3.0 Hz). An extensive examination of the spectroscopic data  
(IR, UV, 1D and 2D NMR, and MS spectra) of 1  and  2 led to their identification as hepta- and 
octaprenylhydroquinones, respectively. All spectral data of 1 and 2 were in agreement with previous 
published data [2,4]. 
The 
1H- and 
13C-NMR spectra of compound 3 were similar to those of compounds 1 and 2, except 
for the presence of signals at δ 4.06 (2H) and δ 60.0, respectively, in the 
1H and 
13C NMR spectra 
(Table  1),  assigned  to  the  primary  alcohol  group  of  the  side  chain,  and  small  differences  in  the 
chemical shifts around the OH group. Further examinations of the 
1H- and 
13C-NMR data of 3 led to its 
identification  as  a  hydroxylated  polyprenylhydroquinone,  close  analogues  of  which  have  been 
previously isolated from S. spinosulus [5,6,20,21]. The molecular formula C51H78O3 of 3 was deduced 
from the HR-MALDITOF-MS data which showed a pseudomolecular adduct ion at m/z 845.4874  
[M  +  Ag]
+  (Calcd.  for  C51H78
107AgO3  845.5001)  [23].  Thus,  NMR  and  MS  data  of  3  led  to  its 
identification  as  a  hydroxylated  nonaprenylhydroquinone  in  which  one  of  the  methyls  has  been 
oxidized  to  hydroxymethylene.  The  position  of  the  OH  group  was  unequivocally  assigned  on  
the  second  isoprene  unit  based  on  the  shift  of  the  olefinic  proton  H-6  to  δ  5.25  (vs.  5.10  in 
polyprenylhydroquinone), and key H-4/H-5/H-6 COSY correlations. Confirmation was given by the 
key H-38/C-6, H-38/C-7, and H-38/C-8 HMBC correlations. Thus, the new natural product 3 was 
identified  as  2′-[38-Hydroxy]nonaprenyl-1′,4′-hydroquinone.  Finally,  the  configurations  of  double 
bonds were all assigned as E by 
1H and 
13C NMR chemical shifts (δ 1.68–1.54 and 17.8–16.1 for  
1H and 
13C, respectively) of the vinyl methyls [24]. 
Table 1. 
1H NMR (500 MHz, CD3OD) and 
13C NMR (125 MHz, CD3OD) data of compound 3. 
No.  δC (ppm)  Mult.  δH (ppm)  J (Hz)  Mult.  COSY  HMBC 
1′  148.9  qC 
         
2′  130.2  qC 
         
3′  117.2  CH  6.52  3.00  d  1  1, 1′, 4′, 5′ 
4′  151.1  qC 
         
5′  113.8  CH  6.41  8.50, 3.00  dd  6′  3′, 4′ 
6′  116.5  CH  6.56  8.50  d  5′  1, 1′, 2, 5′ 
1  29.1  CH2  3.22  7.33  d  2  1′, 2′, 3, 3′ 
2  124.0  CH  5.30 
 
m  1  1, 4 
3  136.8  qC 
         
4  40.9  CH2  1.98 
 
m  5 
 
5  27.7  CH2  2.16 
 
m  4, 6  3, 4, 6, 7 
6  128.8  CH  5.25 
 
m  5 
 
7  139.4  qC 
         
8  35.9  CH2  2.11 
 
m  9  9, 6, 10, 38 
9  27.7  CH2  2.05 
 
m  8, 10 
 
10  125.6  CH  5.10 
 
m  9 
 
11  135.8  qC 
         
12  40.9  CH2  1.96 
 
m 
   
13  27.7  CH2  2.05 
 
m 
   
14  125.6  CH  5.10 
 
m 
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Table 1. Cont. 
15  135.8  qC 
         
16  40.9  CH2  1.96 
 
m 
   
17  27.7  CH2  2.05 
 
m 
   
18  125.6  CH  5.10 
 
m 
   
19  135.8  qC 
         
20  40.9  CH2  1.96 
 
m 
   
21  27.7  CH2  2.05 
 
m 
   
22  125.6  CH  5.10 
 
m 
   
23  135.8  qC 
         
24  40.9  CH2  1.96 
 
m 
   
25  27.7  CH2  2.05 
 
m 
   
26  125.6  CH  5.10 
 
m 
   
27  135.8  qC 
         
28  40.9  CH2  1.96 
 
m 
   
29  27.7  CH2  2.05 
 
m 
   
30  125.6  CH  5.10 
 
m 
   
31  135.8  qC 
         
32  40.9  CH2  1.96 
 
m 
   
33  27.7  CH2  2.05 
 
m 
   
34  125.6  CH  5.10 
 
m 
   
35  135.8  qC 
         
36  25.9  CH3  1.65 
 
s 
 
34, 45 
37  16.2  CH3  1.69 
 
s  1, 2  2, 3, 4 
38  60.0  CH2  4.06 
 
s 
 
6, 7, 8 
39  16.2  CH3  1.58 
 
s 
   
40  16.2  CH3  1.58 
 
s 
   
41  16.2  CH3  1.58 
 
s 
   
42  16.2  CH3  1.58 
 
s 
   
43  16.2  CH3  1.58 
 
s 
   
44  16.2  CH3  1.58 
 
s 
   
45  17.8  CH3  1.58 
 
s 
   
To the best of our knowledge this is the first report on the isolation and structure identification of a 
hydroxylated nonaprenylhydroquinone. Until now, four hydroxylated polyprenylhydroquinones have 
been reported: two heptaprenyl bearing the OH group on the first [20] and fifth prenyl moiety [6]; and 
two octaprenyl congeners bearing the OH group on the fourth [21] and fifth [5] isoprene unit. 
From  a  chemotaxonomic  point  of  view  hydroxylated  polyprenylhydroquinones  could  constitute 
potential markers for S. spinosulus species. 
The  metabolites 1–3  were evaluated for their potential  antileukemic effect towards the chronic 
myelogenous leukemia (CML) cells line K562, which is widely used for cytotoxicity assays. The 
effect of compounds 1–3 was compared with that of Imatinib, the leading compound to treat patients 
suffering  CML.  This  compound  has  proven  very  efficient  in  killing  Bcr-Abl-positive  cells  in  a  
caspase-dependent manner [25,26]. The IC50 values for Imatinib and compounds 1–3 for loss of cell 
metabolism (XTT assay) and cell number are given in Table 2.  Mar. Drugs 2011, 9  
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Table  2.  IC50  values  for  Imatinib  and  compounds  1–3  for  loss  of  cell  metabolism  
(XTT assay) and cell number. Cells (15 ×  10
4/mL) were incubated for 48 h at 37 °C  with 
either  increasing  concentration  of  compounds  1–3  in  the  2.5–250  µM   range  or  with 
Imatinib in the 0.1–2.5 µM  range. Cell metabolism was measured using the XTT assay and 
cell numbers was assessed by flow cytometry as indicated in the Experimental section.  
IC50 values are representative of three experiments made in quadruplicate.  
Compounds 
Cell metabolism   Cell number  
(IC50)  (IC50) 
1  8  7 
2  10  12 
3  193  191 
Imatinib  0.4  0.5 
Compounds  1  and  2  inhibited  cell  metabolism  and  cell  number  with  very  similar  IC50  values 
(around 10 µ M). Compound 3 was less efficient that the two former compounds with IC50 values of 
193 and 191 µ M, respectively. As a control, Imatinib was shown to inhibit cell metabolism and cell 
number with IC50 values of 0.4 and 0.5 µ M, respectively, in agreement with previous results [26].  
As compounds 1 and 2 were also found to induce annexin V externalisation in K562 cells (not shown), 
it is likely that the main mechanism by which both compounds inhibit cells metabolism and cells 
number is by inducing apoptosis. 
3. Experimental Section  
3.1. General 
All  organic  solvents  used  for  material  extraction  were  of  analytical  grade  and  purchased  from 
Merck (Darmstadt, Germany). Acetonitrile used for HPLC was of HPLC-grade and purchased from 
Fisher, USA. Formic acid of HPLC grade was purchased from Acros, USA. 2,5-Dihydroxybenzoic 
acid (DHB, used as the matrix for MALDI-TOF experiments, was of the highest grade available and 
used without further purification) and Silver trifluoroacetate (AgTFA, used as the cationizing agent) 
were purchased from Sigma Aldrich Co. The Chromabond C18 preparative column used for flash 
chromatography was obtained from Merck, USA. Imatinib was kindly provided by Novartis Pharma. 
UV measurements were performed on a Varian Cary 300 Scan UV-visible spectrometer. IR spectra 
were obtained with a Perkin-Elmer Paragon 1000 FT-IR spectrometer. Flash chromatography was 
performed on an Armen Instrument Spot Liquid Chromatography system, the detection wavelength 
was set at 254 nm. HPLC purifications were carried out on a Waters 600 system equipped with a 
Waters 717 plus autosampler, a Waters 996 photodiode array detector, and a Sedex 55 evaporative 
light-scattering detector (SEDERE, France). Detection wavelengths were set at 214, 254 and 280 nm. 
1H and 
13C NMR spectra were recorded with 500 MHz Bruker Avance NMR spectrometers. Chemical 
shifts (δ) are recorded in ppm with CD3OD (δH 3.31 ppm and δC 49.0 ppm) as internal standards with 
multiplicity  (s,  singlet;  d,  doublet;  t,  triplet;  m,  multiplet).  High  resolution  mass  spectra 
(HRMALDITOFMS)  were  conducted  on  a  Perseptive  Voyager  DE-STR  MALDI-TOF  mass 
spectrometer  (Perseptive  Biosystems,  Framingham,  MA,  USA),  equipped  with  a  337  nm  pulsed Mar. Drugs 2011, 9  
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nitrogen laser (20 Hz) and a Acqiris
® 2 GHz digitizer board, was used for all experiments. Mass 
spectra were obtained in reflectron positive ion mode with the following settings: accelerating voltage 
20 kV, grid voltage 62% of accelerating voltage, extraction delay time of 100 ns. The laser intensity 
was set just above the ion generation threshold to obtain peaks with the highest possible signal-to-noise 
(S/N) ratio without significant peak broadening. All data were processed using the Data Explorer 
software package (Applied Biosystems). 
3.2. Sponge Material 
A  sponge  sample  of  Sarcotragus  spinosulus  (Schmidt,  1862)  (Figure  2)  (Demospongiae, 
Dictyoceratida,  Irciniidae)  was  collected  by  hand  using  scuba  at  a  depth  of  about  10  m  from 
Callejones,  Ceuta  in  June  2009.  Taxonomic  examination  of  the  sponge  was  made  by  the  authors  
(C.A. and J.V). The sponge shape is massive and subspherical. The color in situ is dark grey exterior, 
white to beige interior, and in EtOH the flesh color turned slightly to reddish. The texture is difficult to 
tear and has a firm and compressible consistency. The ectosome is unarmoured, thick with conules  
(1  to  2  mm  height)  irregularly  scattered  over  the  entire  surface.  The  choanosome  is  cavernous.  
Its skeleton consists of laminated primary and secondary fibers and comprises very dense spongin 
filaments. Primary fibers (90 to 180 µm diameter) are pithed and clear of foreign detritus. Secondary 
fibers (50 to 100 µm diameter) are uncored, and the spongin filaments are long with a very thin 
diameter of 0.7 to 2 µm . A sponge sample (090618Ce7-05) is kept in the sponge collection of the 
Centre d’Océanologie de Marseille (Station Marine d’Endoume, France). The sponge was kept frozen 
until the extraction process. 
Figure 2. Sarcotragus spinosulus. 
 
3.3. Extraction and Isolation  
A portion of S. spinosulus was freeze-dried and ground to obtain a dry powder (20 g), which was 
exhaustively extracted with a mixture of MeOH/CH2Cl2 (1:1, v/v) to yield 2.2 g of the crude extract 
after  concentration  under  reduced  pressure.  The  crude  extract  was  fractionated  by  RP-C18  flash 
chromatography  (elution  with  a  decreasing  polarity  gradient  of  H2O/MeOH  from  1:0  to  0:1, then 
MeOH/CH2Cl2 from 1:0 to 0:1) (flow: 10 mL/min). The MeOH fraction (448 mg) was then subjected Mar. Drugs 2011, 9  
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to  semi-preparative  HPLC-DAD  (Phenomenex  Luna  C6-Pheny,  250  ×   10  mm  id,  5  µm)  with  a 
gradient  of  H2O/MeCN/Formic  acid  96:4:0.1  to  0:100:0.1)  (flow:  3.0  mL/min,  injection  volume: 
100 µ L) to afford pure compounds 1–3. All of them were identified by a combination of spectroscopic 
methods (1D and 2D NMR, MS) and comparison with the literature data [2,4]. 
3.4. Characterization Data 
Compound 1: HR-MALDITOF-MS m/z 693.3808 [M + Ag]
+ (Calcd. for C41H62
107AgO2, 693.3795); 
For 
1H NMR and 
13C NMR data see [2,4]. 
Compound 2: HR-MALDITOF-MS m/z 761.4389 [M + Ag]
+ (Calcd. for C46H70
107AgO2, 761.4421); 
For 
1H and 
13C NMR data see [2,4]. 
Compound 3: yellow solid; IR (CHC13) 3350, 1500, 1445, 910, 785, 730 cm
−1, UV λmax (MeOH) 
280 nm (ε 2500); HR-MALDITOF-MS m/z 845.4874 [M + Ag]
+ (Calcd. for C51H78
107AgO3, 845.5001); 
For 
1H NMR (500 MHz) and 
13C NMR (125 MHz) data see Table 1. 
3.5. Biological Activity 
Cell Line: The human CML K562 cell line was provided by ATCC and were grown at 37 °C   
under  10%  CO2  in  RPMI  1640  medium  (Gibco  BRL,  Paisley,  UK)  supplemented  with  5%  FCS  
(Gibco BRL, Paisley, UK) completed with 50 units/mL penicillin, 50 mg/mL streptomycin and 1 mM 
sodium pyruvate.  
Measurement of Cell Metabolism (XTT): Cells (15 ×  10
4/mL) were incubated with 1, 2 or 3 for the 
times  indicated.  50  mL  of  XTT  reagent  (sodium  39-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis 
(4-methoxy-6-nitro)benzene sulfonic acid hydrate) was added to each well. Absorbance of the formazan 
dye produced by metabolically active cells was measured at 490 nm as described earlier [27]. Each 
assay was performed in quadruplicate.  
Cell  death  measurement:  After  the  indicated  treatment,  cells  were  harvested  and  percentage of 
viability was measured by propidium iodide (PI) staining (0.5 Ag/mL) and flow cytometry analysis 
in FL-3. 
4. Conclusions  
A  new  hydroxylated  nonaprenylhydroquinone,  2′-[38-Hydroxy]nonaprenyl-1′,4′-hydroquinone, 
along  with  two  known  metabolites,  hepta-  and  octaprenyl-1′,4′-hydroquinones,  have  been  isolated 
from the Mediterranean marine sponge Sarcotragus spinosulus. These compounds exhibited a good 
activity  against  K562  cells  which  will  warrant  further  analysis  at  the  molecular  level  and  offer 
promising opportunities for the development of new antitumor agents. 
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